Business Description
Nordicus Partners Corp
NAICS : 541618
SIC : 8741
ISIN : US28265K3041
Description
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.35 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 69.5 | |||||
3-Year EPS without NRI Growth Rate | 68.8 | |||||
3-Year FCF Growth Rate | 11 | |||||
3-Year Book Growth Rate | 405.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.48 | |||||
9-Day RSI | 74.56 | |||||
14-Day RSI | 70.25 | |||||
3-1 Month Momentum % | -43.89 | |||||
6-1 Month Momentum % | -43.15 | |||||
12-1 Month Momentum % | 25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.46 | |||||
Quick Ratio | 0.46 | |||||
Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -160.7 | |||||
Shareholder Yield % | -5.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -6.29 | |||||
ROA % | -5.36 | |||||
ROIC % | -5.88 | |||||
3-Year ROIIC % | 5.48 | |||||
ROC (Joel Greenblatt) % | -42125 | |||||
ROCE % | -4.58 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.2 | |||||
EV-to-EBIT | -22.87 | |||||
EV-to-EBITDA | -22.9 | |||||
EV-to-FCF | -17.82 | |||||
Earnings Yield (Greenblatt) % | -4.37 | |||||
FCF Yield % | -5.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NORD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nordicus Partners Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.22 | ||
| Beta | -1.2169 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.68 | ||
| Volatility % | 163.58 | ||
| 14-Day RSI | 70.25 | ||
| 14-Day ATR ($) | 0.22524 | ||
| 20-Day SMA ($) | 2.88765 | ||
| 12-1 Month Momentum % | 25 | ||
| 52-Week Range ($) | 1.48 - 5.95 | ||
| Shares Outstanding (Mil) | 19.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nordicus Partners Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nordicus Partners Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2027 | 2027-02-26 | In 182 days | ||
| Second quarter earnings results for 2027 | 2026-11-30 | In 94 days | ||
| First quarter earnings results for 2027 | 2026-08-31 | In 3 days | ||
| General meeting for 2027 | 2026-08-31 | In 3 days | ||
| Annual report for 2026 | 2026-07-14 | 2.45 (+0.00%) | ||
| 0.1:1 Stock Split | 2024-11-08 | 7.50 (+15.38%) |
Show
Entries
Nordicus Partners Corp Frequently Asked Questions
What is Nordicus Partners Corp(NORD)'s stock price today?
The current price of NORD is $4.02. The 52 week high of NORD is $5.95 and 52 week low is $1.48.
When is next earnings date of Nordicus Partners Corp(NORD)?
The next earnings date of Nordicus Partners Corp(NORD) is 2026-08-31 Est..
Does Nordicus Partners Corp(NORD) pay dividends? If so, how much?
Nordicus Partners Corp(NORD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nordicus Partners Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers